c-Met is a receptor tyrosine kinase that, upon activation by its ligand hepatocyte growth factor (HGF), promotes malignant progression and metastasis in multiple cancers, including HCC [11,12]. The gene discussed is MET; the disease is hepatocellular carcinoma.